Ad
related to: biontech and pfizer vaccine
Search results
Jacob Rees-Mogg claims UK government 'downplayed' risks of AstraZeneca COVID vaccine
Yahoo News UK· 7 hours agoFurther analysis by Airfinity showed the AZ and Pfizer/BioNTech vaccines saved more 12 million lives...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance· 5 hours agoNovavax struggled after its COVID-19 vaccine was delayed by manufacturing issues early in...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 8 hours agoWhy it matters: It's a major turnaround for Maryland-based Novavax, one of America's first big bets...
National Academies Report: COVID-19 Vaccines Don’t Cause Many Potential Harms
Journal of the American Medical Association· 20 hours agoThe COVID-19 vaccines made by Pfizer-BioNTech and Moderna do not cause such conditions as female infertility, myocardial infarction, ...
UPDATE 1-BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters via Yahoo Finance· 5 days agoGermany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday that almost ...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 11 hours agoVaccine-maker Novavax announced a $1.2 billion licensing partnership with French pharmaceutical...
What's Going With BioNTech Stock On Monday?
Benzinga· 4 days agoMonday, BioNTech SE BNTX reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss...
Pfizer to test third dose of COVID-19 vaccine in children
AOL· 3 days agoThe decision was made after an analysis showed the two-dose vaccine generated an immune response in...
BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
Barrons.com· 5 days agoFEATURE U.S.-listed shares of BioNTech were falling Monday after the German company that partnered...
BioNTech's Outlook Gives Vaccine Maker a Shot in the Arm
Investopedia· 5 days agoAmerican depositary receipts (ADRs) of BioNTech (BNTX) were down less than 1% in intraday trading...